News & Events

Read the latest, meet us in person.


Most recent news

Willow Biosciences Incorporates Inscripta's Onyx® Platform to Expand Strain Engineering Capabilities and Throughput
Willow Biosciences Inc., a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable…
Read More
Aldevron Licenses the Manufacturing of MAD7, a Type-V CRISPR Nuclease From Inscripta
A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease…
Read More
Ginkgo Bioworks Adopts Inscripta®’s Onyx® Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell…
Read More


Applied Synthetic Biology Europe (ASBE) 2022
November 2nd-4th, 2022, Edinburgh, UK
Join us at the University of Edinburgh for the latest insights on applied synthetic biology research and how it is contributing to progress in…
Efficient and Rapid Discovery of Novel Temperature Sensitive Alleles with the Onyx ® Digital Genome Engineering Platform
September 27, 2022
During this webinar, we will showcase how we leverage the precise, trackable genome editing of the Onyx Platform to discover novel TS alleles in…
Accelerating strain development process for CDMO and CRO companies
July 27, 2022
Manufacturing of proteins, mRNA or small molecules requires comprehensive strain engineering approaches to increase yield, productivity, and…